Search research articles
Contact Us
Filters
Showing results (41-50 of 54) with videos related to
Page
of 6
Sort By:
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
July 26, 2012
Pre- and early in-hospital procedures in patients with acute coronary syndromes: first results of the "German chest pain unit registry"
Felix Post, Evangelos Giannitsis, Thomas Riemer, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
July 1, 2019
Comparison between treatment of "established" versus complex "off-label" coronary lesions with Absorb<sup>®</sup> bioresorbable scaffold implantation: results from the GABI-R<sup>®</sup> registry
Aydin Huseynov, Stefan Baumann, Holger Nef, et al.
BMC Cardiovascular Disorders
|
August 20, 2022
Quality of life of patients with coronary heart disease treated with the bioresorbable vascular scaffold (ABSORB™): 2-year results from the GABI-R-registry
Kathrin Pahmeier, Silke Neusser, Christian Hamm, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
June 30, 2025
Absorb® bioresorbable scaffold in "established" versus "off-label" coronary lesions: 5-year data from the GABI-R® registry
Aydin Huseynov, Michael Behnes, Holger Nef, et al.
Coronary Artery Disease
|
April 10, 2020
Impact of coronary calcification on outcomes after ABSORB scaffold implantation: insights from the GABI-R registry
Rayyan Hemetsberger, Mohammad Abdelghani, Nader Mankerious, et al.
Coronary Artery Disease
|
April 13, 2018
Predictors of early scaffold thrombosis: results from the multicenter prospective German-Austrian ABSORB RegIstRy
Jochen Wöhrle, Holger M Nef, Christoph Naber, et al.
Clinical Hemorheology and Microcirculation
|
January 23, 2023
Rational and design of the REMOTE trial: An exploratory, pilot study to analyze REtinal MicrOcirculaTion in wEightlessness
Stephan Binneboessel, Maryna Masyuk, Kerstin Piayda, et al.
The American Journal of Cardiology
|
December 9, 2022
Rivaroxaban in Patients With Atrial Fibrillation Who Underwent Percutaneous Coronary Intervention in Clinical Practice
Uwe Zeymer, Ralph Toelg, Harm Wienbergen, et al.
Herz
|
March 4, 2022
Current status of antithrombotic therapy and in-hospital outcomes in patients with atrial fibrillation undergoing percutaneous coronary intervention in Germany
Uwe Zeymer, Ralph Toelg, Harm Wienbergen, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
August 31, 2021
Outcomes of 10,312 patients treated with everolimus-eluting bioresorbable scaffolds during daily clinical practice - results from the European Absorb Consortium
Jens Wiebe, Felix J Hofmann, Nick West, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 54) with videos related to
Sort By:
Page
of 6
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
July 26, 2012
Pre- and early in-hospital procedures in patients with acute coronary syndromes: first results of the "German chest pain unit registry"
Felix Post, Evangelos Giannitsis, Thomas Riemer, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
July 1, 2019
Comparison between treatment of "established" versus complex "off-label" coronary lesions with Absorb<sup>®</sup> bioresorbable scaffold implantation: results from the GABI-R<sup>®</sup> registry
Aydin Huseynov, Stefan Baumann, Holger Nef, et al.
BMC Cardiovascular Disorders
|
August 20, 2022
Quality of life of patients with coronary heart disease treated with the bioresorbable vascular scaffold (ABSORB™): 2-year results from the GABI-R-registry
Kathrin Pahmeier, Silke Neusser, Christian Hamm, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
June 30, 2025
Absorb® bioresorbable scaffold in "established" versus "off-label" coronary lesions: 5-year data from the GABI-R® registry
Aydin Huseynov, Michael Behnes, Holger Nef, et al.
Coronary Artery Disease
|
April 10, 2020
Impact of coronary calcification on outcomes after ABSORB scaffold implantation: insights from the GABI-R registry
Rayyan Hemetsberger, Mohammad Abdelghani, Nader Mankerious, et al.
Coronary Artery Disease
|
April 13, 2018
Predictors of early scaffold thrombosis: results from the multicenter prospective German-Austrian ABSORB RegIstRy
Jochen Wöhrle, Holger M Nef, Christoph Naber, et al.
Clinical Hemorheology and Microcirculation
|
January 23, 2023
Rational and design of the REMOTE trial: An exploratory, pilot study to analyze REtinal MicrOcirculaTion in wEightlessness
Stephan Binneboessel, Maryna Masyuk, Kerstin Piayda, et al.
The American Journal of Cardiology
|
December 9, 2022
Rivaroxaban in Patients With Atrial Fibrillation Who Underwent Percutaneous Coronary Intervention in Clinical Practice
Uwe Zeymer, Ralph Toelg, Harm Wienbergen, et al.
Herz
|
March 4, 2022
Current status of antithrombotic therapy and in-hospital outcomes in patients with atrial fibrillation undergoing percutaneous coronary intervention in Germany
Uwe Zeymer, Ralph Toelg, Harm Wienbergen, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
August 31, 2021
Outcomes of 10,312 patients treated with everolimus-eluting bioresorbable scaffolds during daily clinical practice - results from the European Absorb Consortium
Jens Wiebe, Felix J Hofmann, Nick West, et al.
Page
of 6